Clinical Trials Logo

Intranasal Ketamine clinical trials

View clinical trials related to Intranasal Ketamine.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT06139380 Completed - Pain Clinical Trials

Intranasal Ketamine Effectiveness in Reducing Intramuscular Injection Pain Before Sedation Among Children

Start date: December 2, 2023
Phase: Phase 4
Study type: Interventional

Hypothesis: Intranasal administration of ketamine would reduce the intramuscular pain of ketamine injection in children who undergo procedural sedation and analgesia in the emergency department.

NCT ID: NCT03081416 Completed - Headache Clinical Trials

"THINK Trial: Treatment of Headache With IntraNasal Ketamine: A Randomized Controlled Trial Evaluating the Efficacy of Intranasal Ketamine Versus Standard Therapy in the Management of Primary Headache Syndromes in the Emergency Department"

THINK
Start date: May 2016
Phase: Phase 3
Study type: Interventional

This is a randomized, single-blind, placebo controlled trial to evaluate the efficacy of sub-dissociative dose ketamine versus standard care therapy for acute headache management of in patients presenting to the emergency department with headache as the chief compliant.